ATE515576T1 - Protein c polymorphismen - Google Patents

Protein c polymorphismen

Info

Publication number
ATE515576T1
ATE515576T1 AT03727058T AT03727058T ATE515576T1 AT E515576 T1 ATE515576 T1 AT E515576T1 AT 03727058 T AT03727058 T AT 03727058T AT 03727058 T AT03727058 T AT 03727058T AT E515576 T1 ATE515576 T1 AT E515576T1
Authority
AT
Austria
Prior art keywords
patient
protein
inflammatory condition
polymorphisms
polymorphism
Prior art date
Application number
AT03727058T
Other languages
English (en)
Inventor
James Russell
Keith Walley
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE515576T1 publication Critical patent/ATE515576T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT03727058T 2002-05-28 2003-05-28 Protein c polymorphismen ATE515576T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38312802P 2002-05-28 2002-05-28
PCT/CA2003/000751 WO2003100090A2 (en) 2002-05-28 2003-05-28 Protein c polymorphisms

Publications (1)

Publication Number Publication Date
ATE515576T1 true ATE515576T1 (de) 2011-07-15

Family

ID=29584509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03727058T ATE515576T1 (de) 2002-05-28 2003-05-28 Protein c polymorphismen

Country Status (7)

Country Link
US (2) US7820376B2 (de)
EP (1) EP1507872B1 (de)
JP (2) JP2005527218A (de)
AT (1) ATE515576T1 (de)
AU (1) AU2003233292A1 (de)
CA (1) CA2487106A1 (de)
WO (1) WO2003100090A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005219473A1 (en) * 2004-03-04 2005-09-15 The University Of British Columbia Toll-like receptor 2 (TLR-2) haplotypes predict outcome of patients
AU2005219472A1 (en) * 2004-03-04 2005-09-15 The University Of British Columbia Thrombomodulin (THBD) haplotypes predict outcome of patients
CA2479968A1 (en) 2004-09-01 2006-03-01 Keith R. Walley Protein c and endothelial protein c receptor polymorphisms as indicators of patient outcome
AU2007204572A1 (en) * 2006-01-12 2007-07-19 The University Of British Columbia Protein C pathway associated polymorphisms as response predictors to activated protein C or protein C like compound administration
MX2009008788A (es) * 2007-02-16 2009-08-24 Univ British Columbia Poliformismos de serpine1 son predictivos de respuesta a administracion de proteina c activada y riesgo de muerte.
US20110092446A1 (en) * 2007-07-20 2011-04-21 Cedric Francois Compositions and methods for treatment of trauma

Also Published As

Publication number Publication date
WO2003100090A2 (en) 2003-12-04
WO2003100090A3 (en) 2004-04-08
EP1507872B1 (de) 2011-07-06
US20110020825A1 (en) 2011-01-27
US7820376B2 (en) 2010-10-26
AU2003233292A8 (en) 2003-12-12
JP2010142252A (ja) 2010-07-01
US20070128594A1 (en) 2007-06-07
JP2005527218A (ja) 2005-09-15
AU2003233292A1 (en) 2003-12-12
CA2487106A1 (en) 2003-12-04
EP1507872A2 (de) 2005-02-23

Similar Documents

Publication Publication Date Title
Cuyvers et al. Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
DK1071710T4 (da) Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markører deri og fremgangsmåder til påvisning af astma
FI20050011A7 (fi) Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
DK1520039T3 (da) Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose
MY150648A (en) Hla alleles associated with adverse drug reactions and methods for detecting such
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
WO2005098445A3 (en) Lung cancer biomarkers
IL200120A0 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
GB0512401D0 (en) Method
AU2003233292A8 (en) Protein c polymorphisms
WO2007086980A3 (en) Methods of determining the risk of developing coronary artery disease
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
WO2009033282A8 (en) Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
WO2008048902A3 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2008018789A3 (en) Methods and means for diagnosing and treatment of osteoarthritis
ATE466104T1 (de) Als indikatoren zur patientenprognose geeignete haplotypen von plasminogenaktivator-inhibitor-1 (pai-1)
AR043398A1 (es) Metodos de determinacion de un regimen quimioterapeutico basado en la perdida de heterocigosidad en el lugar de timidilato sintasa
NO20060257L (no) Fremgangsmate for diagnostikk og prognostisering av Alzhcimers sykdom
WO2002004683A3 (en) Method of detecting an increased susceptibility to breast cancer
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes
DK1576187T3 (da) Fremgangsmåde til bestemmelse af mængden af cirkulerende DNA i plasma samt påvisning af cancer
DE602007010939D1 (de) Abcbi-genotypisierung zur vorhersage der mikrotubuli-stabilisatorwirkstoffinduzierten toxizität
DE60332158D1 (de) Verfahren zur herzerkrankungsbewertung in einer einzelperson
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties